[HTML][HTML] The chronic mild stress (CMS) model of depression: History, evaluation and usage

P Willner - Neurobiology of stress, 2017 - Elsevier
Now 30 years old, the chronic mild stress (CMS) model of depression has been used in>
1300 published studies, with a year-on-year increase rising to> 200 papers in 2015. Data …

A brief history of the development of antidepressant drugs: from monoamines to glutamate.

TM Hillhouse, JH Porter - Experimental and clinical …, 2015 - psycnet.apa.org
Major depressive disorder (MDD) is a chronic, recurring, and debilitating mental illness that
is the most common mood disorder in the United States. It has been almost 50 years since …

The neurobiology and control of anxious states

MJ Millan - Progress in neurobiology, 2003 - Elsevier
Fear is an adaptive component of the acute “stress” response to potentially-dangerous
(external and internal) stimuli which threaten to perturb homeostasis. However, when …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

SNRIs: the pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants

SM Stahl, MM Grady, C Moret, M Briley - CNS spectrums, 2005 - cambridge.org
The class of serotonin and norepinephrine reuptake inhibitors (SNRIs) now comprises three
medications: venlafaxine, milnacipran, and duloxetine. These drugs block the reuptake of …

The molecular pathophysiology of depression and the new therapeutics

H Tian, Z Hu, J Xu, C Wang - MedComm, 2022 - Wiley Online Library
Major depressive disorder (MDD) is a highly prevalent and disabling disorder. Despite the
many hypotheses proposed to understand the molecular pathophysiology of depression, it is …

Antidepressants and sleep: a qualitative review of the literature

S Wilson, S Argyropoulos - Drugs, 2005 - Springer
Most antidepressants change sleep; in particular, they alter the physiological patterns of
sleep stages recorded overnight with EEG and other physiological measures. These effects …

Defensive burying in rodents: ethology, neurobiology and psychopharmacology

SF De Boer, JM Koolhaas - European journal of pharmacology, 2003 - Elsevier
Defensive burying refers to the typical rodent behavior of displacing bedding material with
vigorous treading-like movements of their forepaws and shoveling movements of their heads …

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

F Borsini, J Podhorna, D Marazziti - Psychopharmacology, 2002 - Springer
Chronically administered antidepressant drugs, particularly selective serotonin (5-HT)
reuptake inhibitors (SSRIs), are clinically effective in the treatment of all anxiety disorders …

Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise

DM Marks, MJ Shah, AA Patkar… - Current …, 2009 - ingentaconnect.com
The precise mechanisms of pain perception and transmission in the central nervous system
have not been fully elucidated. However, extensive data support a role for the monoamine …